Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,628
archived clinical trials in
Schizophrenia

Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated:  12/31/1969
US1403
mi
from
Atlanta, GA
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated: 12/31/1969
US1403
mi
from
Atlanta, GA
Click here to add this to my saved trials
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated:  12/31/1969
US1046
mi
from
Chicago, IL
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated: 12/31/1969
US1046
mi
from
Chicago, IL
Click here to add this to my saved trials
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated:  12/31/1969
US1423
mi
from
Hoffman Estates, IL
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated: 12/31/1969
US1423
mi
from
Hoffman Estates, IL
Click here to add this to my saved trials
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated:  12/31/1969
US1398
mi
from
Shreveport, LA
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated: 12/31/1969
US1398
mi
from
Shreveport, LA
Click here to add this to my saved trials
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated:  12/31/1969
US1404
mi
from
Shreveport, LA
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated: 12/31/1969
US1404
mi
from
Shreveport, LA
Click here to add this to my saved trials
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated:  12/31/1969
US1426
mi
from
Berlin, NJ
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated: 12/31/1969
US1426
mi
from
Berlin, NJ
Click here to add this to my saved trials
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated:  12/31/1969
US1405
mi
from
Glen Oaks, NY
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated: 12/31/1969
US1405
mi
from
Glen Oaks, NY
Click here to add this to my saved trials
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated:  12/31/1969
US1244
mi
from
Jamaica, NY
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated: 12/31/1969
US1244
mi
from
Jamaica, NY
Click here to add this to my saved trials
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated:  12/31/1969
US1394
mi
from
New York, NY
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated: 12/31/1969
US1394
mi
from
New York, NY
Click here to add this to my saved trials
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated:  12/31/1969
US1416
mi
from
New York, NY
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated: 12/31/1969
US1416
mi
from
New York, NY
Click here to add this to my saved trials
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated:  12/31/1969
US1190
mi
from
Staten Island, NY
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated: 12/31/1969
US1190
mi
from
Staten Island, NY
Click here to add this to my saved trials
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated:  12/31/1969
US1390
mi
from
Charlotte, NC
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated: 12/31/1969
US1390
mi
from
Charlotte, NC
Click here to add this to my saved trials
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated:  12/31/1969
US1401
mi
from
Charlotte, NC
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated: 12/31/1969
US1401
mi
from
Charlotte, NC
Click here to add this to my saved trials
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated:  12/31/1969
US1124
mi
from
Norristown, PA
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated: 12/31/1969
US1124
mi
from
Norristown, PA
Click here to add this to my saved trials
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated:  12/31/1969
US1319
mi
from
Charleston, SC
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated: 12/31/1969
US1319
mi
from
Charleston, SC
Click here to add this to my saved trials
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated:  12/31/1969
US1065
mi
from
Dallas, TX
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated: 12/31/1969
US1065
mi
from
Dallas, TX
Click here to add this to my saved trials
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated:  12/31/1969
BG1030
mi
from
Burgas,
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated: 12/31/1969
BG1030
mi
from
Burgas,
Click here to add this to my saved trials
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated:  12/31/1969
US1452
mi
from
Oceanside, CA
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated: 12/31/1969
US1452
mi
from
Oceanside, CA
Click here to add this to my saved trials
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated:  12/31/1969
US1391
mi
from
San Bernardino, CA
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated: 12/31/1969
US1391
mi
from
San Bernardino, CA
Click here to add this to my saved trials
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated:  12/31/1969
US1442
mi
from
Decatur, GA
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated: 12/31/1969
US1442
mi
from
Decatur, GA
Click here to add this to my saved trials
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated:  12/31/1969
US1086
mi
from
Flowood, MS
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated: 12/31/1969
US1086
mi
from
Flowood, MS
Click here to add this to my saved trials
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated:  12/31/1969
US1444
mi
from
Las Vegas, NV
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated: 12/31/1969
US1444
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated:  12/31/1969
US1454
mi
from
Marlton, NJ
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated: 12/31/1969
US1454
mi
from
Marlton, NJ
Click here to add this to my saved trials
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated:  12/31/1969
US1441
mi
from
Hickory, NC
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated: 12/31/1969
US1441
mi
from
Hickory, NC
Click here to add this to my saved trials
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated:  12/31/1969
US1451
mi
from
Austin, TX
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated: 12/31/1969
US1451
mi
from
Austin, TX
Click here to add this to my saved trials
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated:  12/31/1969
US1443
mi
from
Fort Worth, TX
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated: 12/31/1969
US1443
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated:  12/31/1969
US1459
mi
from
Oceanside, CA
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated: 12/31/1969
US1459
mi
from
Oceanside, CA
Click here to add this to my saved trials
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated:  12/31/1969
US1453
mi
from
Tampa, FL
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated: 12/31/1969
US1453
mi
from
Tampa, FL
Click here to add this to my saved trials
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated:  12/31/1969
US1018
mi
from
Bellflower, CA
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated: 12/31/1969
US1018
mi
from
Bellflower, CA
Click here to add this to my saved trials
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated:  12/31/1969
US1464
mi
from
Santa Ana, CA
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated: 12/31/1969
US1464
mi
from
Santa Ana, CA
Click here to add this to my saved trials
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated:  12/31/1969
US1229
mi
from
Orange City, FL
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated: 12/31/1969
US1229
mi
from
Orange City, FL
Click here to add this to my saved trials
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated:  12/31/1969
US1463
mi
from
Culver City, CA
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated: 12/31/1969
US1463
mi
from
Culver City, CA
Click here to add this to my saved trials
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated:  12/31/1969
US1396
mi
from
Washington,
Effect of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Interventional, Randomised, Double-blind, Active-controlled, Fixed-dose Study of Lu AF35700 in Patients With Treatment-resistant Schizophrenia
Status: Enrolling
Updated: 12/31/1969
US1396
mi
from
Washington,
Click here to add this to my saved trials
Benefits of Physical Exercise in Schizophrenia
Physical Exercise Effects on Determinants of Social Integration in Schizophrenia
Status: Enrolling
Updated:  12/31/1969
VA Greater Los Angeles Healthcare System, West Los Angeles, CA
mi
from
West Los Angeles, CA
Benefits of Physical Exercise in Schizophrenia
Physical Exercise Effects on Determinants of Social Integration in Schizophrenia
Status: Enrolling
Updated: 12/31/1969
VA Greater Los Angeles Healthcare System, West Los Angeles, CA
mi
from
West Los Angeles, CA
Click here to add this to my saved trials
Exploratory Trial to Assess the Functionality of an Integrated Call Center for the Digital Medicine System
A Multicenter, 8-week, Open-label, Single-Arm Exploratory Trial to Assess the Functionality of an Integrated Call Center for the Digital Medicine System by Adult Subjects With Schizophrenia, Major Depressive Disorder, or Bipolar 1 Treated With Oral Aripiprazole
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Granada Hills, CA
Exploratory Trial to Assess the Functionality of an Integrated Call Center for the Digital Medicine System
A Multicenter, 8-week, Open-label, Single-Arm Exploratory Trial to Assess the Functionality of an Integrated Call Center for the Digital Medicine System by Adult Subjects With Schizophrenia, Major Depressive Disorder, or Bipolar 1 Treated With Oral Aripiprazole
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Granada Hills, CA
Click here to add this to my saved trials
Exploratory Trial to Assess the Functionality of an Integrated Call Center for the Digital Medicine System
A Multicenter, 8-week, Open-label, Single-Arm Exploratory Trial to Assess the Functionality of an Integrated Call Center for the Digital Medicine System by Adult Subjects With Schizophrenia, Major Depressive Disorder, or Bipolar 1 Treated With Oral Aripiprazole
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Durham, NC
Exploratory Trial to Assess the Functionality of an Integrated Call Center for the Digital Medicine System
A Multicenter, 8-week, Open-label, Single-Arm Exploratory Trial to Assess the Functionality of an Integrated Call Center for the Digital Medicine System by Adult Subjects With Schizophrenia, Major Depressive Disorder, or Bipolar 1 Treated With Oral Aripiprazole
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Durham, NC
Click here to add this to my saved trials
Exploratory Trial to Assess the Functionality of an Integrated Call Center for the Digital Medicine System
A Multicenter, 8-week, Open-label, Single-Arm Exploratory Trial to Assess the Functionality of an Integrated Call Center for the Digital Medicine System by Adult Subjects With Schizophrenia, Major Depressive Disorder, or Bipolar 1 Treated With Oral Aripiprazole
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Richmond, VA
Exploratory Trial to Assess the Functionality of an Integrated Call Center for the Digital Medicine System
A Multicenter, 8-week, Open-label, Single-Arm Exploratory Trial to Assess the Functionality of an Integrated Call Center for the Digital Medicine System by Adult Subjects With Schizophrenia, Major Depressive Disorder, or Bipolar 1 Treated With Oral Aripiprazole
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Richmond, VA
Click here to add this to my saved trials
Exploratory Trial to Assess the Functionality of an Integrated Call Center for the Digital Medicine System
A Multicenter, 8-week, Open-label, Single-Arm Exploratory Trial to Assess the Functionality of an Integrated Call Center for the Digital Medicine System by Adult Subjects With Schizophrenia, Major Depressive Disorder, or Bipolar 1 Treated With Oral Aripiprazole
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Rochester, NY
Exploratory Trial to Assess the Functionality of an Integrated Call Center for the Digital Medicine System
A Multicenter, 8-week, Open-label, Single-Arm Exploratory Trial to Assess the Functionality of an Integrated Call Center for the Digital Medicine System by Adult Subjects With Schizophrenia, Major Depressive Disorder, or Bipolar 1 Treated With Oral Aripiprazole
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Rochester, NY
Click here to add this to my saved trials
Reducing the Weight of Overweight Schizophrenia Patients
A Clinical Trial Of Weight Reduction in Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Western Psychiatric Institute and Clinic of University of Pennsylvania Medical Center
mi
from
Pittsburgh, PA
Reducing the Weight of Overweight Schizophrenia Patients
A Clinical Trial Of Weight Reduction in Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Western Psychiatric Institute and Clinic of University of Pennsylvania Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Best Event Schizophrenia Trial--A Randomized Double-Blind Trial of Aripiprazole and Risperidone in Schizophrenia
A Randomized Double-blind Trial of Aripiprazole and Risperidone in Schizophrenia: An Evaluation of Neuroimaging, Neuropsychological, and Pharmacogenomic Markers of Differential Treatment Response
Status: Enrolling
Updated:  12/31/1969
Wallace Kettering Neuroscience Institute
mi
from
Kettering, OH
Best Event Schizophrenia Trial--A Randomized Double-Blind Trial of Aripiprazole and Risperidone in Schizophrenia
A Randomized Double-blind Trial of Aripiprazole and Risperidone in Schizophrenia: An Evaluation of Neuroimaging, Neuropsychological, and Pharmacogenomic Markers of Differential Treatment Response
Status: Enrolling
Updated: 12/31/1969
Wallace Kettering Neuroscience Institute
mi
from
Kettering, OH
Click here to add this to my saved trials
Multiple Ascending Dose Study of the Safety, Tolerability, Pharmacokinetic/Efficacy
A Phase 2A, Open-Label, Multiple Ascending Dose Study of the Safety, Tolerability, Pharmacokinetics, and Primary Pharmacodynamic Markers of Efficacy of 60mg, 90mg, and 120mg of Risperidone in RBP-7000 Subcutaneous Injections in Subjects With Clinically Stable Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Woodland International Research Group
mi
from
Little Rock, AK
Multiple Ascending Dose Study of the Safety, Tolerability, Pharmacokinetic/Efficacy
A Phase 2A, Open-Label, Multiple Ascending Dose Study of the Safety, Tolerability, Pharmacokinetics, and Primary Pharmacodynamic Markers of Efficacy of 60mg, 90mg, and 120mg of Risperidone in RBP-7000 Subcutaneous Injections in Subjects With Clinically Stable Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Woodland International Research Group
mi
from
Little Rock, AK
Click here to add this to my saved trials
Multiple Ascending Dose Study of the Safety, Tolerability, Pharmacokinetic/Efficacy
A Phase 2A, Open-Label, Multiple Ascending Dose Study of the Safety, Tolerability, Pharmacokinetics, and Primary Pharmacodynamic Markers of Efficacy of 60mg, 90mg, and 120mg of Risperidone in RBP-7000 Subcutaneous Injections in Subjects With Clinically Stable Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Ocean View Psychiatric Health Facility
mi
from
Long Beach, CA
Multiple Ascending Dose Study of the Safety, Tolerability, Pharmacokinetic/Efficacy
A Phase 2A, Open-Label, Multiple Ascending Dose Study of the Safety, Tolerability, Pharmacokinetics, and Primary Pharmacodynamic Markers of Efficacy of 60mg, 90mg, and 120mg of Risperidone in RBP-7000 Subcutaneous Injections in Subjects With Clinically Stable Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Ocean View Psychiatric Health Facility
mi
from
Long Beach, CA
Click here to add this to my saved trials
Open-label Study to Assess Usability of the Medical Information Device #1 (MIND1) System in Adults With Schizophrenia On Oral Aripiprazole
A Multicenter, 8-week, Open-label Study to Assess Usability of the Medical Information Device #1 (MIND1) System in Adult Subjects With Schizophrenia Who Are Treated With Oral Aripiprazole
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Cerritos, CA
Open-label Study to Assess Usability of the Medical Information Device #1 (MIND1) System in Adults With Schizophrenia On Oral Aripiprazole
A Multicenter, 8-week, Open-label Study to Assess Usability of the Medical Information Device #1 (MIND1) System in Adult Subjects With Schizophrenia Who Are Treated With Oral Aripiprazole
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Cerritos, CA
Click here to add this to my saved trials
Open-label Study to Assess Usability of the Medical Information Device #1 (MIND1) System in Adults With Schizophrenia On Oral Aripiprazole
A Multicenter, 8-week, Open-label Study to Assess Usability of the Medical Information Device #1 (MIND1) System in Adult Subjects With Schizophrenia Who Are Treated With Oral Aripiprazole
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Garden Grove, CA
Open-label Study to Assess Usability of the Medical Information Device #1 (MIND1) System in Adults With Schizophrenia On Oral Aripiprazole
A Multicenter, 8-week, Open-label Study to Assess Usability of the Medical Information Device #1 (MIND1) System in Adult Subjects With Schizophrenia Who Are Treated With Oral Aripiprazole
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Garden Grove, CA
Click here to add this to my saved trials
Open-label Study to Assess Usability of the Medical Information Device #1 (MIND1) System in Adults With Schizophrenia On Oral Aripiprazole
A Multicenter, 8-week, Open-label Study to Assess Usability of the Medical Information Device #1 (MIND1) System in Adult Subjects With Schizophrenia Who Are Treated With Oral Aripiprazole
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Oceanside, CA
Open-label Study to Assess Usability of the Medical Information Device #1 (MIND1) System in Adults With Schizophrenia On Oral Aripiprazole
A Multicenter, 8-week, Open-label Study to Assess Usability of the Medical Information Device #1 (MIND1) System in Adult Subjects With Schizophrenia Who Are Treated With Oral Aripiprazole
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Oceanside, CA
Click here to add this to my saved trials
Open-label Study to Assess Usability of the Medical Information Device #1 (MIND1) System in Adults With Schizophrenia On Oral Aripiprazole
A Multicenter, 8-week, Open-label Study to Assess Usability of the Medical Information Device #1 (MIND1) System in Adult Subjects With Schizophrenia Who Are Treated With Oral Aripiprazole
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Atlanta, GA
Open-label Study to Assess Usability of the Medical Information Device #1 (MIND1) System in Adults With Schizophrenia On Oral Aripiprazole
A Multicenter, 8-week, Open-label Study to Assess Usability of the Medical Information Device #1 (MIND1) System in Adult Subjects With Schizophrenia Who Are Treated With Oral Aripiprazole
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
Open-label Study to Assess Usability of the Medical Information Device #1 (MIND1) System in Adults With Schizophrenia On Oral Aripiprazole
A Multicenter, 8-week, Open-label Study to Assess Usability of the Medical Information Device #1 (MIND1) System in Adult Subjects With Schizophrenia Who Are Treated With Oral Aripiprazole
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Chicago, IL
Open-label Study to Assess Usability of the Medical Information Device #1 (MIND1) System in Adults With Schizophrenia On Oral Aripiprazole
A Multicenter, 8-week, Open-label Study to Assess Usability of the Medical Information Device #1 (MIND1) System in Adult Subjects With Schizophrenia Who Are Treated With Oral Aripiprazole
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
Open-label Study to Assess Usability of the Medical Information Device #1 (MIND1) System in Adults With Schizophrenia On Oral Aripiprazole
A Multicenter, 8-week, Open-label Study to Assess Usability of the Medical Information Device #1 (MIND1) System in Adult Subjects With Schizophrenia Who Are Treated With Oral Aripiprazole
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Saint Louis, MO
Open-label Study to Assess Usability of the Medical Information Device #1 (MIND1) System in Adults With Schizophrenia On Oral Aripiprazole
A Multicenter, 8-week, Open-label Study to Assess Usability of the Medical Information Device #1 (MIND1) System in Adult Subjects With Schizophrenia Who Are Treated With Oral Aripiprazole
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Person-Centered Versus Measurement-Based Care in Mental Health
Amplifying the Patient's Voice: Person-Centered Versus Measurement-Based Approaches in Mental Health
Status: Enrolling
Updated:  12/31/1969
Dartmouth Psychiatric Research Center
mi
from
Lebanon, NH
Person-Centered Versus Measurement-Based Care in Mental Health
Amplifying the Patient's Voice: Person-Centered Versus Measurement-Based Approaches in Mental Health
Status: Enrolling
Updated: 12/31/1969
Dartmouth Psychiatric Research Center
mi
from
Lebanon, NH
Click here to add this to my saved trials
Person-Centered Versus Measurement-Based Care in Mental Health
Amplifying the Patient's Voice: Person-Centered Versus Measurement-Based Approaches in Mental Health
Status: Enrolling
Updated:  12/31/1969
UPMC Center for High-Value Health Care
mi
from
Pittsburgh, PA
Person-Centered Versus Measurement-Based Care in Mental Health
Amplifying the Patient's Voice: Person-Centered Versus Measurement-Based Approaches in Mental Health
Status: Enrolling
Updated: 12/31/1969
UPMC Center for High-Value Health Care
mi
from
Pittsburgh, PA
Click here to add this to my saved trials